OAC
SVA

OMERS Administration Corp’s Sinovac Biotech, Ltd SVA Stock Holding History

OMERS Administration Corp’s Portfolio SVA Stock Details SVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-13,900
Closed -$80K – 595
2017
Q1 		$80K Buy
+13,900
New +$80.5K ﹤0.01% 332
2016
Q4 		– Sell
-35,700
Closed -$211K – 673
2016
Q3 		$211K Hold
35,700
– – ﹤0.01% 561
2016
Q2 		$212K Buy
35,700
+1,900
+6% +$11.6K ﹤0.01% 539
2016
Q1 		$216K Buy
+33,800
New +$203K ﹤0.01% 522

Other funds holding SVA

SA
SAIF Advisors Admiralty, Hong Kong $438M AUM
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GP
GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OMERS Administration Corp's SVA Position: Q2 2017 in Review

OMERS Administration Corp sold out of Sinovac Biotech, Ltd (SVA) in Q2 2017, closing a stake of 13,900 shares — an estimated $80K sold.

OMERS Administration Corp first reported a position in SVA in Q1 2016 and held it in 4 quarters. The position peaked at $216K in Q1 2016. 37 funds tracked by Wall St. Rank hold SVA as of Q2 2017.

  • OMERS Administration Corp reported no remaining Sinovac Biotech, Ltd position as of Q2 2017 after selling out during the quarter.
  • OMERS Administration Corp sold 13,900 Sinovac Biotech, Ltd shares in Q2 2017, an estimated $80K.
  • OMERS Administration Corp first reported a position in Sinovac Biotech, Ltd in Q1 2016 and held it in 4 quarters.
  • OMERS Administration Corp's Sinovac Biotech, Ltd position peaked at $216K in Q1 2016.
  • 37 funds tracked by Wall St. Rank held Sinovac Biotech, Ltd as of Q2 2017.

Based on OMERS Administration Corp's 13F filing for Q2 2017, filed 8 Aug 2017.